資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/27863
|
| 標題: | In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates |
| 作者: | Tang, Hung-Jen
Chen, Chi-Chung
Zhang, Chun-Cheng
Su, Bo-An
Li, Chien-Ming
Weng, Tzu-Chieh
Chiang, Shyh-Ren
Ko, Wen-Chien
Chuang, Yin-Ching |
| 貢獻者: | 保健營養系 |
| 關鍵字: | Synergistic Effect
Vancomycin-Resistant Enterococci
Biofilm |
| 日期: | 2013-11 |
| 上傳時間: | 2014-05-26 10:46:44 (UTC+8) |
| 出版者: | Elsevier Science Inc |
| 摘要: | Vancomycin-resistant (VR) enterococci (VRE) are increasingly important nosocomial pathogens, commonly causing catheter-related urinary tract infections or vascular catheter-related bloodstream infections. In this study, 10 Enterococcus faecium and 9 Enterococcus faecalis different pulsed-field gel electrophoresis genome-type VR clinical isolates were detected. The potential role of fosfomycin-based combination regimens for biofilm-related VRE infection is in vitro evaluated. Anti-VRE activities of fosfomycin, ampicillin, linezolid, minocycline, rifampicin, tigecycline, teicoplanin, vancomycin alone, or fosfomycin-based combinations were studied by time-kill method and a biofilm model. Of the fosfomycin-based combinations, a synergistic effect was particularly noted for teicoplanin against 89% of the VR E. faecalis isolates. In a biofilm model, only linezolid alone was able to reduce the bacterial loads, and the use of fosfomycin-based combinations, excluding rifampicin (40%), failed to enhance antibacterial activity against VR E. faecium. For E. faecalis, an inhibitory effect was evident using ampicillin alone or fosfomycin plus rifampicin (100%), tigecycline (56%), or teicoplanin (44%). However, an antagonistic effect was found for ampicillin plus fosfomycin against 2 of 3 of the VR E. faecalis isolates. The antibacterial activities of the drugs tested against VRE in vitro varied by species. Ampicillin exhibited potential activity against planktonic- and biofilm-embedded VR E. faecalis. Fosfomycin-based combinations may have enhanced antibacterial effects against VRE even in the biofilm model, and this observation warrants further clinical studies. (C) 2013 Elsevier Inc. All rights reserved. |
| 關聯: | Diagnostic Microbiology And Infectious Disease, v.77 n.3 pp.254-257 |
| 顯示於類別: | [保健營養系(所) ] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 1582 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
